Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Crossref DOI link: https://doi.org/10.1186/s12886-017-0471-x
Published Online: 2017-05-23
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Waizel, Maria
Todorova, Margarita G.
Masyk, Michael
Wolf, Katharina
Rickmann, Annekatrin
Helaiwa, Khaled
Blanke, Björn R.
Szurman, Peter